NCT03360318 is a NA clinical trial of elbow cast in Radial Fracture, sponsored by Peking University People's Hospital.

Who is sponsoring NCT03360318?

NCT03360318 is sponsored by Peking University People's Hospital.

What drugs are being tested in NCT03360318?

Interventions in NCT03360318: elbow cast, Removable elbow brace.

What condition does NCT03360318 study?

NCT03360318 studies Radial Fracture.

Is NCT03360318 still recruiting?

NCT03360318 is currently status unknown. Last updated 4 December 2017.

Last reviewed 2017-12-04 · How we verify

NCT03360318

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Brace Versus Casting in Pediatric Radial Head Fractures

Status unknown NA Last updated 4 December 2017

What this trial tests

NA trial testing elbow cast in Radial Fracture in 150 participants. Status unknown.

Timeline

2 February 2018

Primary endpoint
5 February 2019

5 February 2019

Quick facts

Lead sponsor	Peking University People's Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	single
Primary purpose	treatment
Enrollment	150
Start date	2 February 2018
Primary completion	5 February 2019
Estimated completion	5 February 2019
Sites	1 location across China

Drugs / interventions tested

elbow cast
Removable elbow brace

Conditions studied

Radial Fracture — all drugs for Radial Fracture →

Sponsor

Peking University People's Hospital

Who can join

Adults 6 to 18, any sex, with Radial Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Commare the pain and function of Brace Versus Casting in Pediatric Radial Head Fractures after 1 month

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Peking University People's Hospital trials

Trials by the same sponsor.

NCT07535645 — Baricitinib for Post-HSCT Persistent Thrombocytopenia · Phase 1, PHASE2 · not yet recruiting
NCT07516002 — Immunoglobulin Efficacy and Immune Profiling in Antibody Immunodeficiency · not yet recruiting
NCT07294339 — A Randomized Controlled Trial of Acupuncture for the Management of Hot Flashes in Patients With Hormone Receptor-Positiv · NA · not yet recruiting
NCT07500441 — Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML · recruiting
NCT07487883 — Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03360318 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking University People's Hospital
Last refreshed: 4 December 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03360318.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing